Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

TS03 Inc Trust Units TSTIF

Healthcare Medical Instruments & Supplies


GREY:TSTIF - Post by User

TS03 Inc Trust Units > According to this The Globe and Mail article,
<< Previous
 Bullboard Posts
Next >>
User Avatar Image
(14)
•••
Comment by eunice12on Nov 15, 2016 10:20am
166 Views
Post# 25462148

RE:RE:RE:According to this The Globe and Mail article,

RE:RE:RE:According to this The Globe and Mail article,
I meant I was just guessing that when you apply for NCIB, the NCIB rules might have some provision to prevent management from selling to the company. It is irrelevant anyway, since TOS doesn't have the cash reserves to support the price with the current heavy volumes. We don't even know what their sales are, because their cash flow projections are all internal.
<< Previous
 Bullboard Posts
Next >>
Dealroom for high-potential pre-IPO opportunities